Home › Mga Sakit sa Puso › Minnesota
Pag-aaral pangklinika para sa Mga Sakit sa Puso sa Minnesota
16 pag-aaral para sa Mga Sakit sa Puso ang naghahanap ng mga kalahok sa mga site sa Minnesota.
Mga Lungsod sa Minnesota
Opisyal na teksto ng pag-aaral (English)
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
- Abbott Northwestern, Minneapolis
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06965504A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
- Minneapolis Heart Institute, Minneapolis
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07286578Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Minneapolis Heart Institute, Minneapolis
- Mayo Clinic, Rochester
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06526195ELEVATE-HFpEF Clinical Study
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
Nagre-recruit
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06678841Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- Abbott Northwestern Hospital, Minneapolis
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT03242642Transition to KPL-387 Monotherapy Dosing & Administration Study
- Investigational Site 028, Rochester
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07288216Clinical Course Of Disease In Participants With FA-CM
- Mayo Clinic, Rochester
Nagre-recruitObservasyonal na pag-aaral
Edad 6 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT06865482A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
- Mayo Clinic, Rochester
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07137338A Study Of Heart Disease Using AI-Enabled Electrocardiography And Focused Cardiac Ultrasound
- Mayo Clinic in Rochester, Rochester
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07351656Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Mayo Clinic - Rochester, Rochester
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06563895PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- University of Minnesota, Minneapolis
- Centra Care Heart Center, Saint Cloud
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT05934487Mayo AVC Registry and Biobank
- Mayo Clinic, Rochester
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT03049254The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- CentraCare Heart and Vascular, Saint Cloud
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT03142152Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
- Mayo Clinic, Rochester
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT06271577Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
- Mayo Clinic, Rochester
Nagre-recruitPhase 1
Edad 18 hanggang 40 · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05647213PARTNER 3 Trial - Aortic Valve-in-Valve
- Mayo Clinic, Rochester
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update May 10, 2024 · NCT03003299Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.